ArticleDiscover oncology2025
A global bibliometric and visualized analysis of the status and trends of lung metastasis in breast cancer research from 2000 to 2024.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tetrandrine-based in situ vaccination via multifunctional Mn²⁺-hyaluronic acid hydrogel loading gelatinase-responsive nanoparticles.Journal of nanobiotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer remains a significant global health challenge, with lung metastasis presenting critical barriers to effective treatment and patient survival. This study conducts the first comprehensive bibliometric and visualized analysis of lung metastasis research in breast cancer from 2000 to 2024, illustrating evolving research trends and collaboration patterns in this critical area. Utilizing data from the Web of Science Core Collection, we employed bibliometric tools such as VOSviewer and CiteSpace to assess publication trends, international collaborations, influential institutions, authors, and keyword dynamics. Our findings reveal a steady increase in annual publications, peaking in 2021, with a significant concentration of research emerging from the USA and China, alongside key insights into molecular mechanisms such as epithelial-mesenchymal transition and immunotherapy. Notably, genes like ERBB2 and ESR1 were identified as pivotal in the metastatic process, highlighting potential therapeutic targets. This study not only illuminates the current landscape of breast cancer lung metastasis research but also underscores the necessity for interdisciplinary collaboration to enhance understanding and treatment strategies for this lethal condition.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.